GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
about
Transglutaminase is a tumor cell and cancer stem cell survival factorInternational Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptorsPhysiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2Adhesion GPCRs in Tumorigenesis.New functions and signaling mechanisms for the class of adhesion G protein-coupled receptors.Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells.Indomethacin induced gene regulation in the rat hippocampusGenome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.Tethered Agonism: A Common Activation Mechanism of Adhesion GPCRs.Contribution of collagen adhesion receptors to tissue fibrosis.7TM Domain Structure of Adhesion GPCRs.Versatile Signaling Activity of Adhesion GPCRs.Structural Basis for Regulation of GPR56/ADGRG1 by Its Alternatively Spliced Extracellular Domains.Stachel-independent modulation of GPR56/ADGRG1 signaling by synthetic ligands directed to its extracellular region.Effect of p53 on pancreatic cancer-glucose tolerance abnormalities by regulating transglutaminase 2 in resistance to glucose metabolic stress.The Adhesion G-Protein-Coupled Receptor, GPR56/ADGRG1, Inhibits Cell-Extracellular Matrix Signaling to Prevent Metastatic Melanoma Growth.The Activation and Signaling Mechanisms of GPR56/ADGRG1 in Melanoma Cell
P2860
Q26799862-2F4E2BA4-C51F-4292-BD8C-5FDD4F332FE3Q28257710-4159D2A3-D2E1-49E4-AC3E-6E470D2A2E89Q28261578-83DB46F0-5495-423E-B5EC-58DFE82A6311Q33558191-63C72D92-C258-49B3-B7D2-2A24C5B63721Q34781716-2B362A11-4EA8-4FD3-BD8E-45AEEFA896D3Q35846184-22024C2D-5D42-41F0-BA98-8A5F498A38A2Q35903542-B25C0C3B-6C2E-4F76-966C-92D516E63181Q36126839-4D4A7316-03AD-4D94-9653-A0DA061C6127Q36355909-7792D549-61FE-4205-8631-2A49C4529E6BQ38796689-A55A4101-1104-46B0-B030-49736B9A8C87Q38879377-6DCDD12F-C543-498B-873C-7D56A4DCABE5Q39004681-927951DB-ED81-451F-9966-9CBED0D38A69Q39004692-F6186A23-942F-4A4E-9213-616BAC96E8F1Q41182997-9CD1DBE2-9B45-4C1E-9CAD-854A76A0BF5EQ42110438-E4B10440-5043-40F6-9BEF-A509DBCEA580Q46271434-7B6E3D4A-9F6D-41FB-B5C6-54B13129C98EQ49449261-9F5D5A04-3C1C-4BA8-B388-2F28B37655CEQ58795528-028ECE97-998E-4637-8D81-E4EDF9E47642
P2860
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
@en
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
@nl
type
label
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
@en
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
@nl
prefLabel
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
@en
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
@nl
P2093
P2860
P1433
P1476
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
@en
P2093
Liquan Yang
Nancy Corson
Scott Friedland
P2860
P304
P356
10.1158/0008-5472.CAN-13-1268
P407
P577
2013-12-19T00:00:00Z